Page last updated: 2024-11-12

pr 39

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

PR 39: antibacterial peptide from pig intestine; MW 4.719 kDa; contains 39 amino acid residues; has high activity against E coli & Bacillus megaterium; amino acid sequence given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

PR-39 : A 39 amino acid porcine cathelicidin that is rich in proline and arginine residues. It plays a pivotal role in the innate immune defence of the pig against infections and exhibits antimicrobial and immunomodulatory activities. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16198954
CHEBI ID131850
MeSH IDM0195722

Synonyms (10)

Synonym
h-arg-arg-arg-pro-arg-pro-pro-tyr-leu-pro-arg-pro-arg-pro-pro-pro-phe-phe-pro-pro-arg-leu-pro-pro-arg-ile-pro-pro-gly-phe-pro-pro-arg-phe-pro-pro-arg-phe-pro-oh
CHEBI:131850
rrrprppylprprpppffpprlpprippgfpprfpprfp
h-l-arg-l-arg-l-arg-l-pro-l-arg-l-pro-l-pro-l-tyr-l-leu-l-pro-l-arg-l-pro-l-arg-l-pro-l-pro-l-pro-l-phe-l-phe-l-pro-l-pro-l-arg-l-leu-l-pro-l-pro-l-arg-l-ile-l-pro-l-pro-gly-l-phe-l-pro-l-pro-l-arg-l-phe-l-pro-l-pro-l-arg-l-phe-l-pro-nh2
pr-39
l-arg-l-arg-l-arg-l-pro-l-arg-l-pro-l-pro-l-tyr-l-leu-l-pro-l-arg-l-pro-l-arg-l-pro-l-pro-l-pro-l-phe-l-phe-l-pro-l-pro-l-arg-l-leu-l-pro-l-pro-l-arg-l-ile-l-pro-l-pro-gly-l-phe-l-pro-l-pro-l-arg-l-phe-l-pro-l-pro-l-arg-l-phe-l-pro
pr 39
139637-11-9
DTXSID90161139
cid 16198954

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In addition, dosage screening and capability of maternal antibody responses were also investigated."( Recombinant plasmids containing CpG with porcine host defense peptides (PR-39/pBD-1) modulates the innate and adaptive intestinal immune responses (including maternal-derived) in piglets.
Cai, H; Cao, D; Deng, J; Jia, J; Li, J; Liang, Q; Ma, M; Ming, F; Zeng, M; Zhang, L; Zhang, S; Zhao, P, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (87)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's23 (26.44)18.2507
2000's43 (49.43)29.6817
2010's20 (22.99)24.3611
2020's1 (1.15)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.74 (24.57)
Research Supply Index4.50 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews9 (10.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other80 (89.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]